What is naloxone? Naloxone is an opioid antagonist that displaces opioids from receptors in the brain, reversing the effects of opioid analgesics, including their life-threatening effects. Naloxone is commercially available by nasal spray (i.e., Narcan® Nasal Spray), solution for injection and an auto-injector (i.e., Evzio®). Currently, naloxone products are only available by prescription. Naloxone is … Read moreWhat you need to know about naloxone
In accordance with the SSN Fraud Prevention Act of 2017, the COB&R program will mask the SSN and SSN-portion of the HICN, on all outgoing letters as of April 1, 2019. The first five digits of the SSN will be masked with asterisks (e.g., *****1234A). All outgoing hardcopy and electronic letters will be included in this … Read moreChanges influencing Medicare Secondary Payer compliance go into effect April 1, 2019
The following is cross-posted from our Optum Insights—Government Affairs blog The U.S. Food and Drug Administration (FDA) recently established a more rapid path for pharmaceutical companies to add over-the-counter (OTC) naloxone products to the market to increase access to naloxone – a life-saving medication used for the emergency treatment of opioid-related overdose – and help … Read moreFDA creates faster way to access over-the-counter naloxone products to treat opioid overdoses
On January 4, 2019, CMS released an updated Non Group Health Plan (NGHP) User Guide, version number 5.5. Click here to access the updated User Guide. Here is a summary of the updates.